(Q44555886)

English

Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)

scientific article published on December 1, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE) (English)

1 reference

Europe PubMed Central

4 December 2017

Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE) (English)

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

myocardial infarction

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

Cardiology and cardiovascular medicine

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

author name string

F. M. Sacks

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746424

14 November 2022

M. A. Pfeffer

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746424

14 November 2022

L. Moye'

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746424

14 November 2022

L. E. Brown

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746424

14 November 2022

P. Hamm

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746424

14 November 2022

T. G. Cole

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746424

14 November 2022

C. M. Hawkins

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746424

14 November 2022

E. Braunwald

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1746424

14 November 2022

language of work or name

0 references

publication date

1 December 1991

1 reference

Europe PubMed Central

4 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:000291499190276Q?httpAccept=text/xml

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

https://api.elsevier.com/content/article/PII:000291499190276Q?httpAccept=text/plain

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

American Journal of Cardiology

1 reference

Europe PubMed Central

4 December 2017

68

1 reference

Europe PubMed Central

4 December 2017

15

1 reference

Europe PubMed Central

4 December 2017

1436-1446

1 reference

Europe PubMed Central

4 December 2017

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

2

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

3

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

4

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Myocardial ischaemia, risk factors and death from coronary heart-disease

5

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Serum lipids and lipoproteins after myocardial infarction: associations with cardiovascular mortality and experience in the Aspirin Myocardial Infarction Study

6

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Natural history of myocardial infarction in the coronary drug project: long-term prognostic importance of serum lipid levels. Coronary Drug Project Research Group

7

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

8

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

11

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality

12

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study

13

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

14

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

15

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

The Oslo diet-heart study. Eleven-year report

17

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region

18

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

The value of lowering cholesterol after myocardial infarction

19

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

20

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

23

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing

26

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

29

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.

32

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins

33

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

An aid to data monitoring in long-term clinical trials

34

1 reference

10.1016/0002-9149(91)90276-Q

https://api.crossref.org/works/10.1016/0002-9149(91)90276-Q

14 November 2022

Identifiers

10.1016/0002-9149(91)90276-Q

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44555886&oldid=1771718855"